DIRS.INFO The most relevant business & tech news

☆ CVS and Walgreens pharmacy staff begin 3-day walkout
▼ + stars: | 2023-10-30 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +3 min

Walgreens and CVS employees are mostly not unionized, which makes a largescale walkout difficult to execute. Workers at Walgreens and CVS have previously staged walkouts in Arizona, Washington, Massachusetts and Oregon in September and early October. During prior walkouts, pharmacy staff feared retaliation from their bosses and corporate leadership, said Jerominski. A spokesperson from the United Food and Commercial Workers International Union (UFCW) told CNN on Sunday that it supports the organizers planning a walkout and protests. “UFCW members and staff have been communicating with many of the CVS and Walgreens workers who have been taking actions to stand up for their rights on the job.

Persons: Shane Jerominski, Jerominski, “, ” Dave Young, Renée Saldaña, “ We’re, Amy Thibault Organizations: New, New York CNN, Employees, Walgreens, CVS, Staff, CNN, Workers, United Food, Commercial Workers International Union, Service Employees International Union, United Healthcare Workers, Retail Pharmacy Union, UFCW, “, West Health, CVS Pharmacy Locations: New York, United States, Arizona , Washington , Massachusetts, Oregon, Southern California, Chicago, North America, West

☆ CVS and Walgreens pharmacy staff plan 3-day walkout
▼ + stars: | 2023-10-30 | by ( Nicole Goodkind | ) edition.cnn.com time to read: +2 min

Staff and organizers in multiple states confirmed to CNN that the walkout and picket lines will take place from October 30 to November 1. Workers at Walgreens and CVS have previously staged walkouts in Arizona, Washington, Massachusetts and Oregon in September and early October. A spokesperson from the United Food and Commercial Workers International Union (UFCW) told CNN on Sunday that it supports the organizers planning a walkout and protests. The Service Employees International Union-United Healthcare Workers West, a California-based healthcare union, also said it supports the walkout and protests. “UFCW members and staff have been communicating with many of the CVS and Walgreens workers who have been taking actions to stand up for their rights on the job.

Persons: Shane Jerominski, “, ” Dave Young, Renée Saldaña Organizations: New, New York CNN, Employees, Staff, CNN, Workers, Walgreens, CVS, United Food, Commercial Workers International Union, Service Employees International Union, United Healthcare Workers, Retail Pharmacy Union, UFCW, “, West Health, ” Locations: New York, United States, Arizona , Washington , Massachusetts, Oregon, California, North America, West

A spokesperson from the United Food and Commercial Workers International Union told CNN that they support the organizers planning a walkout and protests. “We support all health care workers who are organizing and taking a stance to improve staffing.”A Walgreens pharmacy store in Austin, TX. In a statement to CNN, Walgreens said about 20 stores out of about 9,000 had “disruptions over three days,” Oct. 9-11. Walgreens walkout organizers told CNN that their tally is much higher, with about 600 employees participating. The following three Walgreens employees told CNN their reasons for walking out.

Persons: Shane Jerominski, Renée Saldaña, Mohammad Khursheed, Tim Wentworth, Wentworth, ” Fraser Engerman, Engerman, “, ” ‘ We’ve, ”, “ We’ve Organizations: New, New York CNN, Walgreens, Workers, CNN, United Food, Commercial Workers International Union, SEIU, United Healthcare Workers, West Health, Reuters Organizers, “ Locations: New York, West, Austin , TX, Friday’s, Oregon, Wisconsin, Oklahoma

☆ Healthcare VCs are focusing their bets on a handful of top startups, forcing the rest to scramble to stay afloat
▼ + stars: | 2023-07-10 | by ( Rebecca Torrence | ) www.businessinsider.com time to read: +6 min

In the first half of 2023, healthcare investors have written big checks for their top startup picks. 2023 is on track to be the lowest year of healthcare funding since 2019, Rock Health says. Digital-health startups in the US raised $6.1 billion in the first half of 2023, Rock Health's H1 2023 funding report published on Monday found. Right now, 2023 is on track to be the lowest healthcare funding year since 2019, according to Rock Health. Krasniansky said Rock Health expects many of the impending shutdowns to impact healthcare startups that sell products and services to patients online and on-demand, especially direct-to-consumer companies like telemedicine or mail-order-pharmacy startups.

Persons: It's, haven't, Healthcare's, healthcare's, Adriana Krasniansky, Krasniansky, Ian Chiang, he's, Lynne Chou O'Keefe, it's, Corey McCann, Chou O'Keefe, — Organizations: Rock Health, megadeals, Monogram Health, Frist Cressey Ventures, Flare Capital Partners, Define Ventures, Pear, Madison, Pear Therapeutics

☆ Cramer wants to buy more shares of the Club's newest health-care stock — listen to the Homestretch
▼ + stars: | 2023-06-13 | by ( ) www.cnbc.com time to read: 1 min

Cramer wants to buy more shares of the Club's newest health-care stock — listen to the HomestretchCramer said the latest government data showing inflation is cooling could allow the Federal Reserve to pause interest-rate hikes this week, with bullish implications for the market. He also highlighted Club holding Caterpillar (CAT) and Bullpen name Stanley Black & Decker (SWK).

Persons: Cramer, Homestretch Cramer, Stanley Black, Decker Organizations: Federal Reserve, Caterpillar

[1/3] A pharmacist holds a bottle of the drug Eliquis, made by Bristol Myers Squibb and Pfizer, at a pharmacy in Provo, Utah, U.S. January 9, 2020. The government will launch the negotiation process in September by naming the first drugs it plans to target. "We couldn't have the other parts of the IRA without this Medicare negotiation," said Sean Dickson, director of the West Health Policy Center, a non-partisan healthcare think tank. Eliquis, which Bristol Myers (BMY.N) shares with Pfizer (PFE.N), Ibrance, and Imbruvica, sold by AbbVie and Johnson & Johnson (JNJ.N), appear on every list. Pfizer, Novo Nordisk and J&J declined to comment on the likelihood their drugs would be included in the first round of negotiations.

☆ Mark Cuban’s pharmacy startup is actually making drugs less expensive. It's still working on solving the real problem
▼ + stars: | 2022-07-28 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Imatinib, a leukemia medication with a retail price of more than $2,500, is just $14.40 at Cost Plus Drugs. But experts say that Cost Plus Drugs' impact is limited, at least for now, because it hasn't broken into the market driving those exorbitant prices: brand-name drugs. Instead of negotiating prices through those pharmacy benefit managers, Cost Plus Drugs directly negotiates with manufacturers to get generic drugs at wholesale prices. The trade-off: Cost Plus Drugs doesn't accept insurance claims, since insurers don't typically work with pharmacies that avoid pharmacy benefit managers. That gives drugmakers little-to-no incentive to offer rebates to Cost Plus Drugs, Hernandez notes.

Search resuls for: "West Health"

7 mentions found